Press Releases

12345678910
NVIDIA Nemotron Powers Ceramic Supervised Generation to Ground AI Responses at Enterprise Scale
Ceramic, an AI-native search infrastructure company, today unveiled Supervised Generation at NVIDIA GTC 2026 — a system that augments large language model (LLM) outputs with real-time verification, citations and confidence signals. Supervised Generation is model-agnostic, operating as a trust layer alongside any existing LLM infrastructure, with NVIDIA Nemotron 3 Nano as the featured verification engine. To sign up for our waitlist, visit ceramic.ai, or visit us March 16-19 at booth #4035.
By Ceramic · Via Business Wire · March 17, 2026
Pheast Therapeutics to Present Initial Phase 1a Clinical Data and Two New Preclinical Studies of PHST001, a Novel Anti-CD24 Antibody, at AACR 2026
Pheast Therapeutics, a clinical-stage biotechnology company advancing macrophage-directed immunotherapies for cancer, today announced that it will present three abstracts at the American Association for Cancer Research® (AACR) Annual Meeting 2026, taking place April 17–22 in San Diego.
By Pheast Therapeutics · Via Business Wire · March 17, 2026
BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026
SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced it will introduce its next-generation KRAS pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2026. These two non-covalent pan-KRAS inhibitors leverage a differentiated chemical scaffold to address limitations of contemporary molecules - achieving sub-nanomolar potency and a prolonged off-rate, combined with oral bioavailability. In addition, the company will present new preclinical data supporting the continued advancement of its clinical programs BH-30643, a first-in-class, mutant-selective, macrocyclic OMNI-EGFRTM inhibitor, and BH-30236, an oral CLK inhibitor for hematologic malignancies. The AACR Annual Meeting 2026 will be held April 17-22, 2026, in San Diego. 
By BlossomHill Therapeutics, Inc. · Via GlobeNewswire · March 17, 2026
Belitsoft Reviews PHP Development Outsourcing Trends in the USA for 2026
A new report from Belitsoft, a company that specializes in custom software development, shows how U.S. companies are using strategic outsourcing to find senior PHP developers, save up to 60% on costs, and speed up time-to-market with Laravel 13 and PHP 8.3+.
Via AB Newswire · March 17, 2026
Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026
Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced an upcoming poster presentation of initial clinical data from the FORTRESS study of NG-350A, an oncolytic immunotherapy for the treatment of mismatch repair-proficient (pMMR) locally advanced rectal cancer (LARC), at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego.
By Akamis Bio · Via Business Wire · March 17, 2026
SingleCell Biotechnology to Present High-Throughput Single-Cell Phenotyping Platform at AACR Annual Meeting
SingleCell Biotechnology, a biotechnology company developing technologies to measure tumor cell behavior at single-cell resolution, today announced that data from its platform will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, to be held in San Diego, April 17-21, 2026.
By SingleCell Biotechnology · Via Business Wire · March 17, 2026
Soley Therapeutics to Unveil a First-in-Class Small Molecule CKAP2 Modulator with Selective Anti-Tumor Activity at AACR 2026
Soley Therapeutics, a biotechnology company advancing novel therapeutics informed by integrated cell stress biology, today introduced STX-6398, a first-in-class drug candidate with selective anti-tumor activity through modulation of cytoskeleton-associated protein 2 (CKAP2), a previously undruggable protein central to malignant cancer progression. Preclinical data for STX-6398 will be presented at the American Association for Cancer Research® (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego.
By Soley Therapeutics · Via Business Wire · March 17, 2026
Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026
Onchilles Pharma, a private biotech company advancing therapeutics targeting the ELANE pathway, today announced that new preclinical data supporting its systemically delivered NEU-002 program will be presented at the American Association for Cancer Research® (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego. The presentation will highlight the translational development of NEU-002, an engineered therapeutic elastase specifically designed for systemic administration, demonstrating anti-tumor activity via both intravenous and intraperitoneal delivery in solid tumors.
By Onchilles Pharma · Via Business Wire · March 17, 2026
Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026
Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader antibody conjugates (DACs), today announced that new preclinical data on ORM-1153, a CD123-targeting DAC designed to selectively deliver a proprietary GSPT1-degrading payload for the treatment of acute myeloid leukemia (AML), will be presented at the American Association for Cancer Research® (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego.
By Orum Therapeutics · Via Business Wire · March 17, 2026
Parsons Announces New Chief Human Resources Officer
CHANTILLY, Va., March 17, 2026 (GLOBE NEWSWIRE) -- Today, Parsons Corporation (NYSE: PSN) announced a planned transition in its human resources function leadership, promoting Soo Lagasse to chief human resources officer (CHRO), effective April 1, 2026. Lagasse, who currently serves as senior vice president of global talent acquisition and mobility at Parsons, succeeds Susan Balaguer, who notified Parsons’ CEO and board of directors of her intent to retire this spring. Balaguer will remain with Parsons through the end of May to ensure a seamless transition.
By Parsons Services Company · Via GlobeNewswire · March 17, 2026
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
FRANKFURT AM MAIN, Germany, March 17, 2026 (GLOBE NEWSWIRE) -- Anbio Biotechnology (NASDAQ: NNNN) ("Anbio" or the "Company"), a global diagnostic company in in-vitro diagnostic (IVD) technologies, announced today that its CEO will participate in the upcoming KeyBanc Capital Markets Virtual Healthcare Forum on Wednesday, March 18, 2026.
By Anbio Biotechnology · Via GlobeNewswire · March 17, 2026
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that on March 16, 2026 the Company’s Compensation Committee of the Board of Directors (the “Compensation Committee”) granted equity awards to two newly hired employees in the form of restricted stock units (“RSUs”) and non-qualified stock options (“NSOs”) for an aggregate of 38,442 RSUs and 43,000 NSOs as an inducement material to their acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The employment inducement awards were granted under the Company’s 2025 Inducement Plan.
By ImageneBio, Inc. · Via GlobeNewswire · March 17, 2026
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
By Immunocore Holdings plc · Via GlobeNewswire · March 17, 2026
Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days
CALGARY, Alberta, March 17, 2026 (GLOBE NEWSWIRE) -- TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) confirms that its subsidiary, TransAlta Centralia Generation LLC, has received an order (The Order) from the United States Department of Energy. The Order mandates that Centralia Unit 2 in Washington State remain available for operation, for a period of 90 days, until June 14, 2026.
By TransAlta Corporation · Via GlobeNewswire · March 17, 2026
TransAlta Corporation Announces Conversion Results for Series A and B Preferred Shares
CALGARY, Alberta, March 17, 2026 (GLOBE NEWSWIRE) -- Further to TransAlta Corporation's (TransAlta or the Company) (TSX: TA) (NYSE: TAC) press release dated March 2, 2026, the Company announced today that none of its 9,629,913 currently outstanding Cumulative Redeemable Rate Reset First Preferred Shares, Series A (Series A Shares) will be converted on March 31, 2026, on a one-for-one basis, into Cumulative Redeemable Floating Rate First Preferred Shares, Series B (Series B Shares), and (ii) 1,148,549 of its 2,370,087 currently outstanding Series B Shares will be converted on March 31, 2026, on a one-for-one basis, into Series A Shares. As a result, on March 31, 2026, the Company will have 10,778,462 Series A Shares issued and outstanding and 1,221,538 Series B Shares issued and outstanding.
By TransAlta Corporation · Via GlobeNewswire · March 17, 2026
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
SAN FRANCISCO, March 17, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced it will present two preclinical posters at the American Association for Cancer Research (AACR) Annual Meeting taking place April 17-22 in San Diego, California.
By Olema Oncology · Via GlobeNewswire · March 17, 2026
Molecular Partners to Hold Three Poster Presentations at AACR 2026
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will present three posters at the American Association for Cancer Research (AACR) 2026 Annual Meeting, taking place April 17-22 in San Diego, California, USA.
By Molecular Partners · Via GlobeNewswire · March 17, 2026
Robert August Unveils The Berwyn Ave. Knit Trainer, a Fusion of Custom Style and Everyday Comfort
Robert August, a renowned name in handcrafted footwear, is proud to announce the latest addition to its esteemed casual sneaker collection: The Berwyn Ave. Knit Trainer. This lightweight, modern sneaker is engineered for all-day comfort and effortless style, setting a new standard for casual footwear.
Via AB Newswire · March 17, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Sale of Masonite International Corporation Common Stock of Class Action Lawsuit and Upcoming Deadlines – DOOR
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Masonite International Corporation (“Masonite” or the “Company”). (NYSE: DOOR) Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 17, 2026
Asset-Light Car Rental Booking Platforms Are Challenging Traditional Fleet Models in Tourist Economies
In global travel hubs, car rental counters have long been dominated by multinational operators managing capital-intensive fleets financed through debt-heavy balance sheets. But in high-seasonal tourist markets such as Spain’s Canary Islands, a different model is quietly gaining traction — one that relies on digital coordination rather than vehicle ownership.
Via AB Newswire · March 17, 2026
Rosensteel Fleishman Explains Guidance on Handling Serious Car Accident Injuries in Charlotte
A major crash can change your life in a matter of seconds. One moment you are driving through Charlotte on your usual route, and the next you are dealing with ambulance rides, hospital visits, and calls from insurance adjusters. When injuries are serious, the stress can feel overwhelming. Medical bills start arriving quickly, work may be put on hold, and it becomes hard to know who to trust or what steps to take next.
Via AB Newswire · March 17, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · March 17, 2026
420 with CNW — IRS Clarifies Post-Rescheduling 280E MSO Marijuana Tax Arrears
Several large cannabis companies operating across multiple U.S. states collectively owe over $1.6 billion in unpaid federal taxes, according to information disclosed in recent corporate filings. The outstanding balances stem largely from disputes over Internal Revenue Code Section 280E, a provision that significantly limits the deductions marijuana businesses can claim.
Via CannabisNewsWire · March 17, 2026
420 with CNW — IRS Clarifies Post-Rescheduling 280E MSO Marijuana Tax Arrears
Several large cannabis companies operating across multiple U.S. states collectively owe over $1.6 billion in unpaid federal taxes, according to information disclosed in recent corporate filings. The outstanding balances stem largely from disputes over Internal Revenue Code Section 280E, a provision that significantly limits the deductions marijuana businesses can claim.
Via Investor Brand Network · March 17, 2026
Sixth Street Specialty Lending, Inc. Provides a Letter to Stakeholders
Sixth Street Specialty Lending, Inc. (NYSE: TSLX, or the “Company”) today sent the following letter to its stakeholders.
Expanding Access to Trusted Radon Technology for Every Community
San Jose, Calif. - March 17, 2026 - Ecosense®, a global leader in radon detection and monitoring technology, today announced a new partnership with Citizens for Radioactive Radon Reduction (CR3) , a nonprofit organization dedicated to reducing radon-related health risks through education, advocacy, and community-based action. Together, Ecosense and CR3 will expand access to professional-grade digital radon monitors by supporting and growing library lending programs across the United States.
Via AB Newswire · March 17, 2026
INVESTOR ALERT: Camping World Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Camping World Holdings, Inc. (NYSE: CWH) securities between April 29, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), have until May 11, 2026 to seek appointment as lead plaintiff of the Camping World class action lawsuit. Captioned Siverd v. Camping World Holdings, Inc., No. 26-cv-02710 (N.D. Ill.), the Camping World class action lawsuit charges Camping World as well as certain of Camping World’s top current and former executive officers with violations of the Securities Exchange Act of 1934.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. (“PomDoctor” or the “Company”) (NASDAQ: POM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · March 17, 2026
CarzRent Launches Self Service Smart Kiosk Network at Tenerife South Airport - Digital Car Rental Kiosks to Modernize Traveler Services
Costa Adeje, Spain--(Newsfile Corp. - March 17, 2026) - CarzRent, a leading platform in car rental services, is excited to...
Via Newsfile · March 17, 2026
New HEAL Collaborative Analysis Reveals 340B Hospitals Increase Hospital Assets While Reducing Patient Care Spending
A new state-by-state analysis released today by HEAL Collaborative provides further insight into how hospitals participating in the 340B program are allocating resources. The study, titled "The 340B Drug Pricing Program by State: How Covered Entities Are Failing to Invest in Patient Care," was conducted by Magnolia Market Access and provides the first detailed look at how hospitals participating in the federal 340B drug discount program are utilizing program revenues at the state level.
By HEAL Collaborative · Via Business Wire · March 17, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in China Liberal Education Holdings Limited of Class Action Lawsuit and Upcoming Deadlines – CLEUF
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against China Liberal Education Holdings Limited (“CLEU” or the “Company”) (OTCMKTS: CLEUF).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 17, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Paysafe Limited of Class Action Lawsuit and Upcoming Deadlines – PSFE
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Paysafe Limited (“Paysafe” or the “Company”) (NYSE: PSFE).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 17, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BlackRock TCP Capital Corp. of Class Action Lawsuit and Upcoming Deadlines – TCPC
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against BlackRock TCP Capital Corp. (“BlackRock TCP” or the “Company”) (NASDAQ: TCPC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · March 17, 2026
First Internet Bancorp to Pay Cash Dividend
The Board of Directors of First Internet Bancorp (the “Company”) (Nasdaq: INBK) has declared a quarterly cash dividend of $0.06 per common share. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on March 31, 2026.
By First Internet Bancorp · Via Business Wire · March 17, 2026
NiSource declares common stock dividend
The board of directors of NiSource Inc. (NYSE: NI) today declared a quarterly common stock dividend payment of $0.30 cents per share, payable May 20, 2026, to stockholders of record at the close of business on April 30, 2026.
By NiSource Inc. · Via Business Wire · March 17, 2026
PublicSquare to Present at 38th Annual Roth Conference
PSQ Holdings, Inc. (NYSE: PSQH) (the “Company”), a payments and financial infrastructure company, today announced that Dusty Wunderlich, Chairman and Chief Executive Officer, will participate in a fireside chat at the upcoming 38th Annual Roth Investor Conference on Tuesday, March 24, 2026, at 10:30 a.m. PT (1:30 p.m. ET). A link to the webcast will be available at investors.publicsquare.com. Attendees should log in to the webcast approximately 15 minutes before the presentation starts.
By PSQ Holdings, Inc. · Via Business Wire · March 17, 2026
Andersen Reports Record Fourth-Quarter and Full-Year 2025 Financial Results and Initiates 2026 Guidance
Andersen Group Inc. (NYSE: ANDG) today released financial results for the fourth quarter and full year ended December 31, 2025.
By Andersen Group Inc. · Via Business Wire · March 17, 2026
Titan America Announces Fourth Quarter and Full Year 2025 Results
Titan America SA (NYSE: TTAM), a leading fully-integrated producer and supplier of building materials, services and solutions in the construction industry operating along the U.S. East Coast, today announced its fourth quarter and full year 2025 financial results. Titan America SA, including its wholly-owned operating subsidiary, Titan America LLC, shall be referred to herein as “Titan America.”
By Titan America SA · Via Business Wire · March 17, 2026
New Fortress Energy Schedules Informational Call
New Fortress Energy Inc. (NASDAQ: NFE) (“NFE” or the “Company”) will host a conference call on Wednesday, March 18, 2026 at 8:30 AM Eastern Time. The conference call may be accessed by dialing 800-330-6710 (toll-free from within the U.S.) or +1 646-769-9200 (from outside of the U.S.) fifteen minutes prior to the scheduled start of the call; please reference “NFE Informational Call” or conference code 3978309.
By New Fortress Energy Inc. · Via Business Wire · March 17, 2026
Imperative Care Announces $100 Million Financing
Imperative Care, Inc., a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the closing of an oversubscribed $100 million convertible note financing.
By Imperative Care, Inc. · Via Business Wire · March 17, 2026
INVESTOR ALERT: Trip.com Group Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Trip.com Group Limited (NASDAQ: TCOM) publicly traded securities between April 30, 2024 and January 13, 2026, both dates inclusive (the “Class Period”), have until May 11, 2026 to seek appointment as lead plaintiff of the Trip.com class action lawsuit. Captioned De Wilde v. Trip.com Group Limited, No. 26-cv-01420 (E.D.N.Y.), the Trip.com class action lawsuit charges Trip.com as well as certain of Trip.com’s top executive officers with violations of the Securities Exchange Act of 1934.
object studio Introduces Bella: A Modern Loyalty Platform for Casinos
object studio announces the launch of Bella, a new loyalty product line built for land-based casino properties. A unified ecosystem spanning loyalty mobile apps, on-property kiosks, member portals, and digital signage: Bella represents object studio’s first fully productized platform following more than a decade of building casino industry solutions.
By object studio · Via Business Wire · March 17, 2026
Super League Sets Fourth Quarter and Full Year 2025 Earnings Date, March 27, 2026
SANTA MONICA, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company connecting brands with people who play video games, one of the largest and most value audiences shaping modern culture, announced today that the Company will post its fourth quarter and full year 2025 financial results before market open on Friday, March 27, 2026. A webinar will be held the same day at 8:30 am Eastern Time to discuss the results and can be accessed using the below dial-in numbers or registration link.
By Super League Enterprise · Via GlobeNewswire · March 17, 2026
ROSEN, THE FIRST FILING FIRM, Encourages Kyndryl Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KD
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · March 17, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines – RARE
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 
By Pomerantz LLP · Via GlobeNewswire · March 17, 2026
Michael Mumbauer of California Launches “Build the Future Responsibly” Personal Pledge on Ethical AI in Creative Industries
SAN DIEGO, CA - March 17, 2026 - Michael Mumbauer of California, founder and CEO of Liithos and a longtime creative leader in video games and digital storytelling, has announced a new personal initiative focused on the responsible use of generative AI in creative industries. The initiative, called the “Build the Future Responsibly” pledge, outlines a set of personal commitments Mumbauer will follow as artificial intelligence continues to reshape how stories, games, and media are produced.
Via Get News · March 17, 2026
Genius Sports Announces Availability of Its 2025 Annual Report on Form 20-F
Genius Sports Limited (“Genius Sports”) (NYSE:GENI) today announced that its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 has been filed with the Securities and Exchange Commission.
By Genius Sports · Via Business Wire · March 17, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · March 17, 2026
Varandeep Grewal Advocates for Global Financial Literacy and Long-Term Thinking
Varandeep Grewal, founder and president of Grewal Capital Corp, is speaking out about the importance of financial literacy and long-term economic awareness as global markets become more complex and interconnected.
Via Get News · March 17, 2026
Paycom Receives HCM Technology Signal Award for Workforce Change
Paycom Software, Inc. (NYSE: PAYC) (“Paycom”), a leading provider of comprehensive, cloud‑based human capital management software, today announced it has received the H3 HR Advisors HCM Technology Signal Award for workforce change. This award recognizes Paycom’s consistent impact through innovations such as decisioning logic and automation across its HR and payroll software, which help organizations navigate significant transformation.
By Paycom Software, Inc. · Via Business Wire · March 17, 2026